Q1 2013

Source filing unavailable

Q1 2013 · —

Revenue

$133.44M

+20.8% vs Q1 2012

Net Income

$30.14M

+20.1% vs Q1 2012

EPS Diluted

$0.36

+24.1% vs Q1 2012

Operating Income$48,582,000+17.1%

Operating Cash Flow$51,356,000+61.4%

Free Cash Flowderived

Same quarter

Metric	Q1 2013	Q1 2012	Q1 2011	Q1 2010
Revenue	$133.44M	$110.45M	$91.86M	$85.12M
Net Income	$30.14M	$25.10M	$22.54M	$30.44M
EPS Diluted	$0.36	$0.29	$0.24	$0.31

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR